Sonoma Pharmaceuticals (SNOA) Tops Q3 EPS by 6c

Sonoma Pharmaceuticals (NASDAQ: SNOA) reported Q3 EPS of ($0.63), $0.06 better than the analyst estimate of ($0.69). Revenue for the quarter came in at $3.6 million versus the consensus estimate of $4 million.

For earnings history and earnings-related data on Sonoma Pharmaceuticals (SNOA) click here.

You May Also Be Interested In

• SpaceX (SPCX) call put ratio 2 calls to 1 put as share price at $160
• Rivian stock jumps 5% on raised delivery outlook
• Moderna (MRNA) call put ratio 5 calls to 1 put with a focus on July 10 weekly 80 and 85 calls as share price up 6.5%